MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'anti psychotic'. Sat, 03 Sep 2011 02:21:44 +0100 http://www.medworm.com/index.php?rid=3798610&cid=t_142025_109_f&fid=34750&url=http%3A%2F%2Fpsychcentral.com%2Fblog%2Farchives%2F2010%2F07%2F28%2Fwithdrawing-from-psychiatric-medications%2F This article offers only the most basic of introductions to this topic, because others have covered this area far more extensively than I have. A great place to start is this psychiatric drug withdrawal primer. While not succinct, it does contain all of the information you’ll need to know to successfully end your psychiatric medication treatment. I cannot emphasize this enough — discontinuing psychiatric medications on your own is not recommended. You should enlist your doctor in your efforts to stop the meds. (Source: World of Psychology) World of Psychology blogs http://www.medworm.com/rss/comments.php?id=3798610 Wed, 28 Jul 2010 10:30:19 +0100 3798610 http://www.medworm.com/index.php?rid=2996010&cid=t_142025_137_f&fid=35426&url=http%3A%2F%2Funcnews.unc.edu%2Fimages%2Fstories%2Fnews%2Fhealth%2F2008%2Fdrugslist.pdf Falls are the leading cause of both fatal and nonfatal injuries for adults sixty-five and older, and research suggests that those taking four or more medications are at an even greater risk than those who don’t—perhaps two to three times greater. -- Susan Blalock, UNC Eshelman School of Pharmacy.....Bob DeMarco Alzheimer's Reading Room Editor I am always worried that my mother might fall and injure herself -- or worse. Research studies indicate that falling is a leading cause of injury deaths for people 65 and older -- see Falls Among Older Adults: An Overview. More than one third of adults 65 and older fall each year in the United States Twenty percent to 30% of people who fall suffer moderate to severe injuries such as bruises, hip fractures, or head traumas. Men are more likel... Alzheimer's Reading Room, The blogs http://www.medworm.com/rss/comments.php?id=2996010 Sun, 15 Nov 2009 17:37:51 +0100 2996010 http://www.medworm.com/index.php?rid=4060671&cid=t_142025_109_f&fid=34859&url=http%3A%2F%2Fblog.davemsw.com%2Farchives%2F2009%2F09%2Fgenerics_versus_brands_are_they_really_the_same.php This is a topic that gets scant attention leaving the consuming public largely in the dark. Even though I work in the field, I've not hear this information except from my own reading. Fortunately, SSRIs are not as susceptible to problems crossing from brands to generics or between generics. But buproprion in other forms may not be as good as Wellbutrin. Image via WikipediaMedical News "Antidepressant and antipsychotic drugs have become blockbusters for the firms that developed them, making them hot markets for generic competition. Moreover, the effectiveness of these drugs is measured in the same way as anticonvulsants -- either they work or they don't. Consequently, psychiatry is another specialty that has had to think about how to handle the variability in potency among generics. Mic... Ψ Dare To Dream... blogs http://www.medworm.com/rss/comments.php?id=4060671 Tue, 22 Sep 2009 01:53:11 +0100 4060671 http://www.medworm.com/index.php?rid=1968950&cid=t_142025_133_f&fid=35096&url=http%3A%2F%2Ffeeds.b5media.com%2F%7Er%2Fb5media%2FAutismVox%2F%7E3%2FmYGKhOuS2lU%2F More than 389,000 children and teenagers were treated with Risperdal—an atypical antipsychotic—last year. And, 240,000 of them were 12 years old or younger, the November 18th New York Times reports. A panel of federal drug experts stated that medications like Risperdal are ” being used far too cavalierly in children” and that “federal drug regulators must do more to warn doctors of their substantial risks.” Risperdal has been approved for treating irritability in autistic children. The New York Times notes that “in many cases, the drug was prescribed to treat attention deficit disorders,” for which it has not been approved for: The meeting on Tuesday was scheduled to be a routine review of the pediatric safety of Risperdal and Zyprexa, popula... Autism Vox blogs http://www.medworm.com/rss/comments.php?id=1968950 Wed, 19 Nov 2008 06:30:32 +0100 1968950 http://www.medworm.com/index.php?rid=1754718&cid=t_142025_87_f&fid=34935&url=http%3A%2F%2Fmedicine.com.my%2Fwp%2F%3Fp%3D4318 Magnesium Sulphate & Cerebral Palsy, Beta-Amyloid & Brain Injury, Antipsychotic Drugs & Stroke Risk a Magnesium Sulphate & Cerebral Palsy, Beta-Amyloid & Brain Injury, Antipsychotic Drugs & Stroke Risk (Source: Malaysian Medical Resources) Malaysian Medical Resources blogs http://www.medworm.com/rss/comments.php?id=1754718 Tue, 02 Sep 2008 04:00:00 +0100 1754718 http://www.medworm.com/index.php?rid=1352024&cid=t_142025_109_f&fid=34750&url=http%3A%2F%2Fpsychcentral.com%2Fblog%2Farchives%2F2008%2F04%2F04%2Fstudy-suggests-antipsychotics-dont-help-people-with-dementia-alzheimers%2F Powerful antipsychotic medications have commonly been prescribed to people with Alzheimer’s disease and other serious cognitive dementias found amongst the elderly population, especially if they are in a nursing home or hospital environment. Why? Almost all older dementia patients will experience, along with the cognitive and functional decline typical of the illness, some neuropsychiatric symptoms. These symptoms can include agitation, aggression, and psychosis, and are often devastating for the older patient and his or her family and caregiver. Managing these symptoms is often a prime concern for health-care providers and families. Neuroleptics (sometimes called antipsychotics) are the class of drugs often used to manage or control neuropsychiatric problems, but there have been... World of Psychology blogs http://www.medworm.com/rss/comments.php?id=1352024 Fri, 04 Apr 2008 15:00:54 +0100 1352024 http://www.medworm.com/index.php?rid=551514&cid=t_142025_97_f&fid=35050&url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmaGazette%2F%7E3%2F109997186%2Fnew_dose_of_risperdal_consta_f.html The USFDA has recently approved the new 12.5 mg dose of RISPERDAL® CONSTA® [(risperidone) Long-Acting Injection] for the treatment of schizophrenia within specific patient populations (including those with renal and hepatic impairment). Manufactured by Alkermes, Inc. (Nasdaq: ALKS) RISPERDAL® CONSTA® is marketed in the U.S. by Janssen, L.P. and was approved for the treatment of schizophrenia in the U.S. in 2003. The new 12.5 mg dose of RISPERDAL® CONSTA® is expected to be available in the U.S. market by May 1. According to Henry Nasrallah, M.D., Professor of Psychiatry and Neuroscience, and Director of the Schizophrenia Research Program at the University of Cincinnati: "The 12.5 mg dose of RISPERDAL CONSTA will help clinicians to customize treatment for each pa... PharmaGazette blogs http://www.medworm.com/rss/comments.php?id=551514 Wed, 18 Apr 2007 10:35:12 +0100 551514 http://www.medworm.com/index.php?rid=4060788&cid=t_142025_109_f&fid=34859&url=http%3A%2F%2Fblog.davemsw.com%2Farchives%2F2006%2F11%2Fthe_importance_of_early_and_ef.php There is an important new research study on treatment of schizophrenia. They have found delayed or interrupted treatment is associated with permanent lost brain function and less success in recovery. That is indeed my clinical experience with schizophrenia and bipolar disorder. Any kind of chronic brain dysfunction makes permanent changes to brain structures and functioning. PTSD has been associated with permenent changes in emotion intensity and increased difficulty in emotion regulation. Chemical abuse has been associated with brain changes as well. When the brain is involved, respond quickly, ask for help and persist to be sure the treatment is effective. Anything less will cost you in brain function. This applies to any serious mental health or neurological problem. Psychiatric Weekl... Ψ Dare To Dream... blogs http://www.medworm.com/rss/comments.php?id=4060788 Tue, 14 Nov 2006 01:46:53 +0100 4060788 http://www.medworm.com/index.php?rid=4060795&cid=t_142025_109_f&fid=34859&url=http%3A%2F%2Fblog.davemsw.com%2Farchives%2F2006%2F10%2Flatest_schizophrenia_study_int.php Anti-psychotic medication has gotten very expensive, especially when compared to long standing generics. Now research is finding the generics work just as well as the new "atypicals". But the fact is, medication has to be subscribed one client at a time. While on average, some of the generics work as well with low side effects, some individuals have extreme side effects from the generics or don't benefit from them any where near as effectively as the new "atypicals". In particular, the worse permanent side effect, tardive dyskinesia appears less likely with new atypicals in individuals prone to that problem. So when we have journal articles pointing out the excesses of the pharmeceutical industry, we need to be sure we don't eliminate the best option for the minority of persons who need ... Ψ Dare To Dream... blogs http://www.medworm.com/rss/comments.php?id=4060795 Thu, 19 Oct 2006 03:06:16 +0100 4060795 http://www.medworm.com/index.php?rid=4060836&cid=t_142025_109_f&fid=34859&url=http%3A%2F%2Fblog.davemsw.com%2Farchives%2F2006%2F04%2Fnew_research_finds_the_full_ra.php Some of you might remember the report released last year saying that an older medication Trilafon was just as effective as the new MUCH more expensive medications. Even though NIMH commented later that the research did not support that belief, many Medicaid programs wrote the new medications out of their formularies. A follow-up to this research has reinforced the fact that most psychiatrists already know. Each person's body chemistry responds uniquely to each medication. The full range of medicaitons are required to find an effective choice. Besides, the side effect profile is much better for the newer medications. The permanent neurological damage evidenced by tardive dyskinesia too often caused by the older medications were often an unacceptable consequence of appropriate treatment. P... Ψ Dare To Dream... blogs http://www.medworm.com/rss/comments.php?id=4060836 Fri, 07 Apr 2006 04:15:12 +0100 4060836 http://www.medworm.com/index.php?rid=4060868&cid=t_142025_109_f&fid=34859&url=http%3A%2F%2Fblog.davemsw.com%2Farchives%2F2005%2F09%2Fare_antipsychotic_medications.php This study provides the largest, longest, and most comprehensive independent trial ever conducted to study existing therapies for this disease. It will provide valuable information to help physicians and patients choose the most appropriate medication for them. There is considerable variation among individuals; what works for one does not necessarily work for another. It is important to have a variety of treatment options. The CATIE study provides specific information, on therapeutic effects as well as side effects, about those options. [...] The investigators will continue to study other important outcomes, including cost-effectiveness, quality of life, and predictors of response. As additional results from CATIE are analyzed, disseminated, and put into context, the hope is that the cumul... Ψ Dare To Dream... blogs http://www.medworm.com/rss/comments.php?id=4060868 Tue, 20 Sep 2005 00:24:17 +0100 4060868 http://www.medworm.com/index.php?rid=4060889&cid=t_142025_109_f&fid=34859&url=http%3A%2F%2Fblog.davemsw.com%2Farchives%2F2005%2F04%2Fdoctors_warned_not_to_use_anti.php Anti-psychotic drug warning for seniors with dementia U.S. health officials Monday advised physicians not to give elderly patients with dementia anti-psychotic drugs approved for other medical conditions. The Food and Drug Administration said the drugs included in the warning were Abilify (aripiparozole), Zyprexa (olanzapine), Seroquel (quetiapine), Risperdal (risperidone), Clozaril (clozapine) and Geodon (ziprasidone). All are approved for treatment of schizophrenia and mania but are associated with a higher death rate when given to elderly patients with dementia for behavioral problems. Symbyax, approved for depression linked to biopolar disorder, also was included in the advisory. Manufacturers of these drugs must add a boxed warning to their labels, FDA said, describing the risk and ... Ψ Dare To Dream... blogs http://www.medworm.com/rss/comments.php?id=4060889 Sun, 24 Apr 2005 19:28:35 +0100 4060889 http://www.medworm.com/index.php?rid=4060893&cid=t_142025_109_f&fid=34859&url=http%3A%2F%2Fblog.davemsw.com%2Farchives%2F2005%2F04%2Fdoctors_should_monitor_metabol.php Psychiatrists are doing a "modest" job of monitoring for weight gain, diabetes and other metabolic problems that may result from use of the newer antipsychotics for schizophrenia, researchers say. Nearly all of the 258 members of the American Psychiatric Association in Georgia, Ohio and Iowa responding to a survey said they considered metabolic side effects serious or very serious, said researchers from the Medical College of Georgia, University of Iowa and Northcoast Behavioral Healthcare in Ohio. However, monitoring for these problems - including getting baseline data on personal and family health history as well as baseline and regular checks of height and body weight, waist circumference, blood pressure, fasting blood glucose and lipid levels - largely goes undone, researchers said o... Ψ Dare To Dream... blogs http://www.medworm.com/rss/comments.php?id=4060893 Sun, 24 Apr 2005 05:21:19 +0100 4060893